AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$1.12
−6.67%Margins
Gross margin
-234.1%
EBITDA margin
-1205.6%
EBIT margin
-1290.3%
Net margin
-7691.5%
FCF margin
-1819.1%
334.8%
Return on equity
-791.9%
Return on assets
-254.9%
Return on invested capital
0.10x
Asset turnover
-$9.5M
Cash from operations
$0.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026